HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Harvey D White Selected Research

Unstable Angina

10/2022Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES.
8/2022Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
1/2022Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial.
1/2022B-Type Natriuretic Peptide and Long-Term Cardiovascular Mortality in Patients With Coronary Heart Disease.
1/2021Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial.
1/2021Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.
11/2020Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.
1/2020Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.
1/2020Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.
1/2020Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Harvey D White Research Topics

Disease

187Myocardial Infarction
10/2022 - 06/2002
165Acute Coronary Syndrome
10/2022 - 01/2002
129Hemorrhage
03/2022 - 02/2002
58Ischemia
03/2022 - 09/2002
58Stroke (Strokes)
12/2021 - 12/2002
49ST Elevation Myocardial Infarction
01/2022 - 09/2002
45Coronary Disease (Coronary Heart Disease)
10/2022 - 03/2002
43Thrombosis (Thrombus)
03/2022 - 06/2002
32Unstable Angina
10/2022 - 07/2002
30Heart Failure
01/2022 - 01/2002
22Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 01/2002
21Infarction (Infarctions)
03/2020 - 02/2002
16Atrial Fibrillation
01/2022 - 12/2002
15Atherosclerotic Plaque (Atheroma)
01/2022 - 11/2004
14Ischemic Stroke
10/2022 - 12/2011
11Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 03/2002
10Left Ventricular Dysfunction
01/2018 - 08/2003
8Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 01/2002
8Inflammation (Inflammations)
12/2021 - 11/2004
8Atherosclerosis
10/2017 - 02/2009
7Hypertension (High Blood Pressure)
01/2022 - 01/2002
7Stable Angina
11/2018 - 07/2008
7Non-ST Elevated Myocardial Infarction
01/2018 - 09/2002
7Diabetes Mellitus
12/2017 - 02/2009
6Obesity
07/2019 - 08/2008
6Pathologic Constriction (Stenosis)
06/2014 - 01/2003
5Chronic Renal Insufficiency
01/2022 - 08/2009
5Dyslipidemias (Dyslipidemia)
01/2022 - 10/2017
5Renal Insufficiency (Renal Failure)
01/2022 - 01/2007
5Transient Ischemic Attack
11/2019 - 02/2010
5Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2018 - 02/2004
5Vascular Diseases (Vascular Disease)
10/2018 - 06/2006
5Neoplasms (Cancer)
01/2018 - 01/2016
5Bundle-Branch Block (Fascicular Block)
06/2014 - 01/2000
5Cardiogenic Shock
06/2014 - 10/2003
4Type 2 Diabetes Mellitus (MODY)
01/2021 - 10/2018
4Cardiomyopathies (Cardiomyopathy)
01/2020 - 04/2015
4Peripheral Arterial Disease
01/2020 - 10/2014
4Thrombocytopenia (Thrombopenia)
01/2018 - 02/2011

Drug/Important Bio-Agent (IBA)

56Clopidogrel (Plavix)FDA Link
01/2022 - 11/2006
51Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 06/2002
35Glycoproteins (Glycoprotein)IBA
01/2018 - 06/2002
34bivalirudin (Angiomax)FDA Link
03/2020 - 02/2002
33Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2022 - 03/2002
32Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2017 - 06/2002
32Enoxaparin (Lovenox)FDA LinkGeneric
07/2013 - 09/2002
31cangrelorIBA
03/2022 - 12/2009
26alirocumabIBA
10/2022 - 11/2018
26Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2004
24Prasugrel HydrochlorideFDA Link
01/2020 - 06/2009
21vorapaxarIBA
12/2018 - 03/2011
20darapladibIBA
01/2022 - 04/2011
20Thrombin Receptors (Thrombin Receptor)IBA
01/2020 - 01/2012
18TroponinIBA
01/2022 - 07/2008
18StreptokinaseFDA Link
06/2019 - 06/2002
17omega-Chloroacetophenone (Mace)IBA
10/2022 - 02/2011
17CreatinineIBA
01/2022 - 12/2002
15LipidsIBA
01/2022 - 03/2002
14Pravastatin (Pravachol)FDA LinkGeneric
01/2022 - 10/2002
13LDL CholesterolIBA
10/2022 - 06/2015
13Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022 - 04/2003
13AntithrombinsIBA
01/2012 - 06/2002
12Valsartan (Vals)FDA Link
04/2014 - 08/2003
11oxidized low density lipoproteinIBA
10/2022 - 12/2011
11C-Reactive ProteinIBA
01/2018 - 11/2003
8pro-brain natriuretic peptide (1-76)IBA
01/2021 - 11/2004
81-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
10/2017 - 10/2011
8Platelet Membrane Glycoprotein IIbIBA
05/2015 - 12/2002
7CholesterolIBA
12/2020 - 10/2002
7Tissue Plasminogen Activator (Alteplase)FDA Link
01/2018 - 01/2007
7Hemoglobins (Hemoglobin)IBA
04/2017 - 03/2008
7Troponin T (Troponin T1)IBA
01/2017 - 03/2003
7Pharmaceutical PreparationsIBA
01/2016 - 02/2009
7Warfarin (Coumadin)FDA LinkGeneric
03/2014 - 02/2007
6Lipoproteins (Lipoprotein)IBA
08/2022 - 04/2011
6Proprotein Convertase 9IBA
08/2022 - 11/2018
6Lipoprotein(a)IBA
01/2021 - 12/2013
6Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2011
6Tirofiban (Aggrastat)FDA Link
01/2016 - 08/2002
5TicagrelorIBA
01/2022 - 02/2011
5AnticoagulantsIBA
03/2020 - 06/2002
52'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2020 - 01/2016
5Troponin IIBA
01/2018 - 09/2008
5Creatine Kinase (Creatine Phosphokinase)IBA
07/2009 - 01/2002
5sibrafibanIBA
08/2007 - 08/2003
5Platelet Membrane GlycoproteinsIBA
02/2007 - 07/2002
4Cystatin CIBA
01/2022 - 01/2017
4Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2022 - 03/2011
4Interleukin-6 (Interleukin 6)IBA
12/2021 - 10/2017
4Peptide Hydrolases (Proteases)FDA Link
12/2018 - 03/2014
4thienopyridineIBA
03/2017 - 02/2009
4PAR-1 ReceptorIBA
01/2016 - 07/2014

Therapy/Procedure

121Therapeutics
08/2022 - 06/2002
89Percutaneous Coronary Intervention
03/2022 - 06/2002
44Stents
03/2022 - 08/2002
35Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2020 - 09/2004
22Thrombolytic Therapy
01/2022 - 01/2000
10Patient Readmission
03/2017 - 09/2002
7Blood Transfusion (Blood Transfusions)
01/2018 - 12/2007
5Secondary Prevention
12/2018 - 08/2003